---
title: "Rilonacept - Cryopyrin associated periodic syndrome"
sidebar: mydoc_sidebar
permalink: db06372-mesh-d056587-1.html
toc: false 
---


Path ID: `DB06372_MESH_D056587_1`
{% include image.html url="images/db06372-mesh-d056587-1.png" file="db06372-mesh-d056587-1.png" alt="db06372-mesh-d056587-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C531377 | rilonacept | Drug |
| UniProt:P01584 | Interleukin-1 beta | Protein |
| UniProt:P01583 | Interleukin-1 alpha | Protein |
| UniProt:P18510 | Interleukin-1 receptor antagonist protein | Protein |
| GO:0070498 | interleukin-1-mediated signaling pathway | BiologicalProcess |
| GO:0006954 | Inflammation | BiologicalProcess |
| MESH:D056587 | Cryopyrin associated periodic syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Rilonacept | DECREASES ACTIVITY OF | Interleukin-1 Beta |
| Rilonacept | DECREASES ACTIVITY OF | Interleukin-1 Alpha |
| Rilonacept | DECREASES ACTIVITY OF | Interleukin-1 Receptor Antagonist Protein |
| Interleukin-1 Beta | PARTICIPATES IN | Interleukin-1-Mediated Signaling Pathway |
| Interleukin-1 Alpha | PARTICIPATES IN | Interleukin-1-Mediated Signaling Pathway |
| Interleukin-1 Receptor Antagonist Protein | PARTICIPATES IN | Interleukin-1-Mediated Signaling Pathway |
| Interleukin-1-Mediated Signaling Pathway | POSITIVELY REGULATES | Inflammation |
| Inflammation | CAUSES | Cryopyrin Associated Periodic Syndrome |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB06372](https://go.drugbank.com/drugs/DB06372)
